Osteoporosis is an under-screened musculoskeletal disorder that results in diminished quality of life and significant burden to the healthcare system. We aimed to evaluate the ability of Rho, an artificial intelligence (AI) tool, to prospectively identify patients at-risk for low bone mineral density (BMD) from standard x-rays, its adoption rate by radiologists, and acceptance by primary care providers (PCPs). Patients ≥50 years were recruited when undergoing an x-ray of a Rho-eligible body part for any clinical indication. Questionnaires were completed at baseline and 6-month follow-up, and PCPs of "Rho-Positive" patients (those likely to have low BMD) were asked for feedback. Positive predictive value (PPV) was calculated in patients who returned within 6 months for a DXA. Of 1145 patients consented, 987 had x-rays screened by Rho, and 655 were flagged as Rho-Positive. Radiologists included this finding in 524 (80%) of reports. Of all Rho-Positive patients, 125 had a DXA within 6 months; Rho had a 74% PPV for DXA T-Score <-1. From 51 PCP responses, 78% found Rho beneficial. Of 389 patients with follow-up questionnaire data, a greater proportion of Rho-Positive versus -negative patients had discussed bone health with their PCP since study start (36% vs 18%, <i>P</i> < .001), or were newly diagnosed with osteoporosis (11% vs 5%; <i>P</i> = .03). By identifying patients at-risk of low BMD, with acceptability of reporting by radiologists and generally positive feedback from PCPs, Rho has the potential to improve low screening rates for osteoporosis by leveraging existing x-ray data.

Tuberculosis (TB) is a serious infectious disease that remains a global health challenge. While chest X-rays (CXRs) are widely used for TB detection, manual interpretation can be subjective and time-consuming. Automated classification of CXRs into TB and non-TB cases can significantly support healthcare professionals in timely and accurate diagnosis. This paper introduces a hybrid deep learning approach for classifying CXR images. The solution is based on the CoAtNet framework, which combines the strengths of Convolutional Neural Networks (CNNs) and Vision Transformers (ViTs). The model is pre-trained on the large-scale ImageNet dataset to ensure robust generalization across diverse images. The evaluation is conducted on the IN-CXR tuberculosis dataset from ICMR-NIRT, which contains a comprehensive collection of CXR images of both normal and abnormal categories. The hybrid model achieves a binary classification accuracy of 86.39% and an ROC-AUC score of 93.79%, outperforming tested baseline models that rely exclusively on either CNNs or ViTs when trained on this dataset. Furthermore, the integration of Local Interpretable Model-agnostic Explanations (LIME) enhances the interpretability of the model's predictions. This combination of reliable performance and transparent, interpretable results strengthens the model's role in AI-driven medical imaging research. Code will be made available upon request.

The COVID-19 pandemic has been the most catastrophic global health emergency of the [Formula: see text] century, resulting in hundreds of millions of reported cases and five million deaths. Chest X-ray (CXR) images are highly valuable for early detection of lung diseases in monitoring and investigating pulmonary disorders such as COVID-19, pneumonia, and tuberculosis. These CXR images offer crucial features about the lung's health condition and can assist in making accurate diagnoses. Manual interpretation of CXR images is challenging even for expert radiologists due to the overlapping radiological features. Therefore, Artificial Intelligence (AI) based image processing took over the charge in healthcare. But still it is uncertain to trust the prediction results by an AI model. However, this can be resolved by implementing explainable artificial intelligence (XAI) tools that transform a black-box AI into a glass-box model. In this research article, we have proposed a novel XAI-TRANS model with inception based transfer learning addressing the challenge of overlapping features in multiclass classification of CXR images. Also, we proposed an improved U-Net Lung segmentation dedicated to obtaining the radiological features for classification. The proposed approach achieved a maximum precision of 98% and accuracy of 97% in multiclass lung disease classification. By leveraging XAI techniques with the evident improvement of 4.75%, specifically LIME and Grad-CAM, to provide detailed and accurate explanations for the model's prediction.

Bone age assessment is essential in evaluating pediatric growth disorders. Artificial intelligence (AI) systems offer potential improvements in accuracy and reproducibility compared to traditional methods. To compare the performance of a commercially available artificial intelligence-based software (BoneView BoneAge, Gleamer, Paris, France) against two human-assessed methods-the Greulich-Pyle (GP) atlas and Tanner-Whitehouse version 2 (TW2)-in a pediatric population. This proof-of-concept study included 203 pediatric patients (mean age, 9.0 years; range, 2.0-17.0 years) who underwent hand and wrist radiographs for suspected endocrine or growth-related conditions. After excluding technically inadequate images, 157 cases were analyzed using AI and GP-assessed methods. A subset of 35 patients was also evaluated using the TW2 method by a pediatric endocrinologist. Performance was measured using mean absolute error (MAE), root mean square error (RMSE), bias, and Pearson's correlation coefficient, using chronological age as reference. The AI model achieved a MAE of 1.38 years, comparable to the radiologist's GP-based estimate (MAE, 1.30 years), and superior to TW2 (MAE, 2.86 years). RMSE values were 1.75 years, 1.80 years, and 3.88 years, respectively. AI showed minimal bias (-0.05 years), while TW2-based assessments systematically underestimated bone age (bias, -2.63 years). Strong correlations with chronological age were observed for AI (r=0.857) and GP (r=0.894), but not for TW2 (r=0.490). BoneView demonstrated comparable accuracy to radiologist-assessed GP method and outperformed TW2 assessments in this cohort. AI-based systems may enhance consistency in pediatric bone age estimation but require careful validation, especially in ethnically diverse populations.

Cystic bronchiectasis and pneumonia are respiratory conditions that significantly impact morbidity and mortality worldwide. Diagnosing these diseases accurately is crucial, as early detection can greatly improve patient outcomes. These diseases are respiratory conditions that present with overlapping features on chest X-rays (CXR), making accurate diagnosis challenging. Recent advancements in deep learning (DL) have improved diagnostic accuracy in medical imaging. This study proposes the EffConvNeXt model, a hybrid approach combining EfficientNetB1 and ConvNeXtTiny, designed to enhance classification accuracy for cystic bronchiectasis, pneumonia, and normal cases in CXRs. The model effectively balances EfficientNetB1's efficiency with ConvNeXtTiny's advanced feature extraction, allowing for better identification of complex patterns in CXR images. Additionally, the EffConvNeXt model combines EfficientNetB1 and ConvNeXtTiny, addressing limitations of each model individually: EfficientNetB1's SE blocks improve focus on critical image areas while keeping the model lightweight and fast, and ConvNeXtTiny enhances detection of subtle abnormalities, making the combined model highly effective for rapid and accurate CXR image analysis in clinical settings. For the performance analysis of the EffConvNeXt model, experimental studies were conducted using 5899 CXR images collected from Dicle University Medical Faculty. When used individually, ConvNeXtTiny achieved an accuracy rate of 97.12%, while EfficientNetB1 reached 97.79%. By combining both models, the EffConvNeXt raised the accuracy to 98.25%, showing a 0.46% improvement. With this result, the other tested DL models fell behind. These findings indicate that EffConvNeXt provides a reliable, automated solution for distinguishing cystic bronchiectasis and pneumonia, supporting clinical decision-making with enhanced diagnostic accuracy.

To deploy an AI model to measure limb-length discrepancy (LLD) and prospectively validate its performance. We encoded the inference of an LLD AI model into a docker container, incorporated it into a computational platform for clinical deployment, and conducted two prospective validation studies: a shadow trial (07/2024-9/2024) and a clinical trial (11/2024-01/2025). During each trial period, we queried for LLD EOS scanograms to serve as inputs to our model. For the shadow trial, we hid the AI-annotated outputs from the radiologists, and for the clinical trial, we displayed the AI-annotated output to the radiologists at the time of study interpretation. Afterward, we collected the bilateral femoral and tibial lengths from the radiology reports and compared them against those generated by the AI model. We used median absolute difference (MAD) and interquartile range (IQR) as summary statistics to assess the performance of our model. Our shadow trial consisted of 84 EOS scanograms from 84 children, with 168 femoral and tibial lengths. The MAD (IQR) of the femoral and tibial lengths were 0.2 cm (0.3 cm) and 0.2 cm (0.3 cm), respectively. Our clinical trial consisted of 114 EOS scanograms from 114 children, with 228 femoral and tibial lengths. The MAD (IQR) of the femoral and tibial lengths were 0.3 cm (0.4 cm) and 0.2 cm (0.3 cm), respectively. We successfully employed a computational platform for seamless integration and deployment of an LLD AI model into our clinical workflow, and prospectively validated its performance. Question No AI models have been clinically deployed for limb-length discrepancy (LLD) assessment in children, and the prospective validation of these models is unknown. Findings We deployed an LLD AI model using a homegrown platform, with prospective trials showing a median absolute difference of 0.2-0.3 cm in estimating bone lengths. Clinical relevance An LLD AI model with performance comparable to that of radiologists can serve as a secondary reader in increasing the confidence and accuracy of LLD measurements.

The application of artificial intelligence (AI) in medical imaging has revolutionized diagnostic practices, enabling advanced analysis and interpretation of radiological data. This study presents a comprehensive evaluation of radiomics-based and deep learning-based approaches for disease detection in chest radiography, focusing on COVID-19, lung opacity, and viral pneumonia. While deep learning models, particularly convolutional neural networks (CNNs) and vision transformers (ViTs), learn directly from image data, radiomics-based models extract handcrafted features, offering potential advantages in data-limited scenarios. We systematically compared the diagnostic performance of various AI models, including Decision Trees, Gradient Boosting, Random Forests, Support Vector Machines (SVMs), and Multi-Layer Perceptrons (MLPs) for radiomics, against state-of-the-art deep learning models such as InceptionV3, EfficientNetL, and ConvNeXtXLarge. Performance was evaluated across multiple sample sizes. At 24 samples, EfficientNetL achieved an AUC of 0.839, outperforming SVM (AUC = 0.762). At 4000 samples, InceptionV3 achieved the highest AUC of 0.996, compared to 0.885 for Random Forest. A Scheirer-Ray-Hare test confirmed significant main and interaction effects of model type and sample size on all metrics. Post hoc Mann-Whitney U tests with Bonferroni correction further revealed consistent performance advantages for deep learning models across most conditions. These findings provide statistically validated, data-driven recommendations for model selection in diagnostic AI. Deep learning models demonstrated higher performance and better scalability with increasing data availability, while radiomics-based models may remain useful in low-data contexts. This study addresses a critical gap in AI-based diagnostic research by offering practical guidance for deploying AI models across diverse clinical environments.

Artificial intelligence is increasingly being integrated into clinical diagnostics, yet its lack of transparency hinders trust and adoption among healthcare professionals. The explainable AI (XAI) has the potential to improve interpretability and reliability of AI-based decisions in clinical practice. This study evaluates the use of Explainable AI (XAI) for interpreting radiology reports to improve healthcare practitioners' confidence and comprehension of AI-assisted diagnostics. This study employed the Indiana University chest X-ray Dataset containing 3169 textual reports and 6471 images. Textual were being classified as either normal or abnormal by using a range of machine learning approaches. This includes traditional machine learning models and ensemble methods, deep learning models (LSTM), and advanced transformer-based language models (GPT-2, T5, LLaMA-2, LLaMA-3.1). For image-based classifications, convolution neural networks (CNNs) including DenseNet121, and DenseNet169 were used. Top performing models were interpreted using Explainable AI (XAI) methods SHAP and LIME to support clinical decision making by enhancing transparency and trust in model predictions. LLaMA-3.1 model achieved highest accuracy of 98% in classifying the textual radiology reports. Statistical analysis confirmed the model robustness, with Cohen's kappa (k=0.981) indicating near perfect agreement beyond chance, both Chi-Square and Fisher's Exact test revealing a high significant association between actual and predicted labels (p<0.0001). Although McNemar's Test yielded a non-significant result (p=0.25) suggests balance class performance. While the highest accuracy of 84% was achieved in the analysis of imaging data using the DenseNet169 and DenseNet121 models. To assess explainability, LIME and SHAP were applied to best performing models. These models consistently highlighted the medical related terms such as "opacity", "consolidation" and "pleural" are clear indication for abnormal finding in textual reports. The research underscores that explainability is an essential component of any AI systems used in diagnostics and helpful in the design and implementation of AI in the healthcare sector. Such approach improves the accuracy of the diagnosis and builds confidence in health workers, who in the future will use explainable AI in clinical settings, particularly in the application of AI explainability for medical purposes.

This study aimed to identify the most effective diagnostic assistance system for assessing the relationship between mandibular third molars (M3M) and mandibular canals (MC) using panoramic radiographs. In total, 2,103 M3M were included from patients in whom the M3M and MC overlapped on panoramic radiographs. All M3M were classified into high-risk and low-risk groups based on the degree of contact with the MC observed on computed tomography. The contact classification was evaluated using four machine learning models (Prediction One software, AdaBoost, XGBoost, and random forest), three convolutional neural networks (CNNs) (EfficientNet-B0, ResNet18, and Inception v3), and three human observers (two radiologists and one oral surgery resident). Receiver operating characteristic curves were plotted; the area under the curve (AUC), accuracy, sensitivity, and specificity were calculated. Factors contributing to prediction of high-risk cases by machine learning models were identified. Machine learning models demonstrated AUC values ranging from 0.84 to 0.88, with accuracy ranging from 0.81 to 0.88 and sensitivity of 0.80, indicating consistently strong performance. Among the CNNs, ResNet18 achieved the best performance, with an AUC of 0.83. The human observers exhibited AUC values between 0.67 and 0.80. Three factors were identified as contributing to prediction of high-risk cases by machine learning models: increased root radiolucency, diversion of the MC, and narrowing of the MC. Machine learning models demonstrated strong performance in predicting the three-dimensional relationship between the M3M and MC.

Manufacturer-defined AI thresholds for chest x-ray (CXR) often lack customization options. Threshold optimization strategies utilizing users' clinical real-world data along with pathology-enriched validation data may better address subgroup-specific and user-specific needs. A pathology-enriched dataset (study cohort, 563 (CXRs)) with pleural effusions, consolidations, pneumothoraces, nodules, and unremarkable findings was analysed by an AI system and six reference radiologists. The same AI model was applied to a routine dataset (clinical cohort, 15,786 consecutive routine CXRs). Iterative receiver operating characteristic analysis linked achievable sensitivities (study cohort) to resulting AI alert rates in clinical routine inpatient or outpatient subgroups. "Optimized" thresholds (OTs) were defined by a 1% sensitivity increase leading to more than a 1% rise in AI alert rates. Threshold comparisons (OTs versus AI vendor's default thresholds (AIDT) versus Youden's thresholds) were based on 400 clinical cohort cases with expert radiologists' reference. AIDTs, OTs, and Youden's thresholds varied across scenarios, with OTs differing based on tailoring for inpatient or outpatient CXRs. AIDT lowering most reasonably improved sensitivity for pleural effusion, with increases from 46.8% (AIDT) to 87.2% (OT) for outpatients and from 76.3% (AIDT) to 93.5% (OT) for inpatients; similar trends appeared for consolidations. Conversely, regarding inpatient nodule detection, increasing the threshold improved accuracy from 69.5% (AIDT) to 82.5% (OT) without compromising sensitivity. Graphical analysis supports threshold selection by illustrating estimated sensitivities and clinical routine AI alert rates. An innovative, subgroup-specific AI threshold optimization is proposed, automatically implemented and transferable to other AI algorithms and varying clinical subgroup settings. Individually customizing thresholds tailored to specific medical experts' needs and patient subgroup characteristics is promising and may enhance diagnostic accuracy and the clinical acceptance of diagnostic AI algorithms. Customizing AI thresholds individually addresses specific user/patient subgroup needs. The presented approach utilizes pathology-enriched and real-world subgroup data for optimization. Potential is shown by comparing individualized thresholds with vendor defaults. Distinct thresholds for in- and outpatient CXR AI analysis may improve perception. The automated pipeline methodology is transferable to other AI models or subgroups.